China Cord Blood (CO) Tops Q3 EPS by 5c

China Cord Blood (NYSE: CO) reported Q3 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $26.1 million versus the consensus estimate of $27 million.

New subscribers and accumulated subscriber base were 15,603 and 489,796, respectively. The new subscriber number decreased by 11.5% year-over-year.

For earnings history and earnings-related data on China Cord Blood (CO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold